Skip to main content

Table 3 Effect size of text-based clinical updates

From: A controlled trial of the effectiveness of internet continuing medical education

CME ACTIVITY

Participants

Non-participants

Effect size

 

N

Mean % evidence-based response

SD

N

Mean % evidence-based response

SD

 

Psychiatry

       

Identifying patients with prodromal schizophrenia

35

73

12

28

49

16

1.76

Treatment nonadherence among individuals with schizophrenia

52

71

17

47

54

21

0.90

Treatment resistant schizophrenia

50

77

18

50

60

15

1.08

Reducing suicide risk in patients with schizophrenia

49

81

21

46

59

27

0.92

Recognizing and preventing abuse of rapid-onset opioids

50

68

21

57

48

21

0.93

Detecting autism in a toddler

100

68

19

102

50

22

0.85

Hyperactivity or autism

101

61

19

95

47

20

0.73

Infectious disease

       

Maximizing therapeutic success in an era of increasing antibiotic resistance

43

73

27

43

51

28

0.80

The role of antibiotics in serious hospital acquired infections

47

87

20

54

71

19

0.82

Fungal infection in the immunocompromised patient

47

68

21

39

54

21

0.65

Urology

       

Prostate cancer

26

71

24

28

49

19

0.28

Lower urinary tract symptoms in men

24

74

23

24

58

20

0.77

Evaluation and treatment of overactive bladder

41

74

29

45

63

28

0.37

Erectile dysfunction and cardiovascular disease

29

63

14

25

57

22

0.32

Cardiology

       

Statin efficacy and prevention of recurrent stroke

22

83

11

22

60

16

1.62

Diabetes, Metabolic Syndrome and very low cholesterol

59

88

21

59

72

30

0.62

Statins in the treatment of heart failure

50

60

18

49

45

19

0.83

Advances in hypertension

22

82

18

22

58

27

1.04

Medical adherence

22

55

22

22

38

16

0.89

Analysis of latest trial data points to new guidelines & restructured hypertension therapy

50

85

19

49

59

25

1.04

Neurology

       

The role of MRI in multiple sclerosis diagnosis and management

53

64

21

53

46

19

0.89

Breakthrough pain

73

75

27

73

48

29

0.98

Rheumatology

       

Risks and benefits of COX-2 selective inhibitors

85

70

23

98

62

24

0.36

Women's health

       

Contraception today

18

79

21

21

57

20

1.12